OverviewChartNewsTraderScreen

Soc. Generale Knock-Out AZN/  DE000SF6V5X5  /

EUWAX
17/05/2024  08:18:01 Chg.-0.11 Bid22:00:45 Ask22:00:45 Underlying Strike price Expiration date Option type
4.75EUR -2.26% -
Bid Size: -		 -
Ask Size: -		 Astrazeneca PLC ORD ... 80.3948 GBP 31/12/2078 Call
GlobeNewswire 08/05 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 06/05 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 06/05 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 02/05 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 29/04 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 28/03 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 18/03 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 14/03 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 14/03 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 28/02 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 26/02 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 26/02 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 22/02 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 22/02 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 20/02 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 09/02 Europe mostly lower premarket amid German CPI, earnings
TeleTrader 08/02 Europe closes mostly higher following earnings
TeleTrader 08/02 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 08/02 AstraZeneca's revenue in Q4 rises 5% to $11.3B
GlobeNewswire 05/02 Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire 02/02 BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...
GlobeNewswire 10/01 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors